In vivo formation of a Schiff base of aminoguanidine with pyridoxal phosphate.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Biochemical Pharmacology

• Publication date

  1998-05-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0006-2952(98)00010-0PMID 9634003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat

  2004cited by this paper
• Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats

  1997cited by this paper
• Highly sensitive and simple liquid chromatographic determination in plasma of B6 vitamers, especially pyridoxal 5'-phosphate.

  1996cited by this paper
• Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.

  1996cited by this paper
• Mice lacking tissue non–specific alkaline phosphatase die from seizures due to defective metabolism of vitamin B–6

  1995cited by this paper
• Effects of aminoguanidine and pyridoxal phosphate on glycation reaction of aspartate aminotransferase and serum albumin.

  1995cited by this paper
• Advanced glycosylation endproducts in diabetic renal disease: clinical measurement, pathophysiological significance, and prospects for pharmacological inhibition.

  1995cited by this paper
• Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation

  1993cited by this paper
• Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine

  1992cited by this paper
• Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats

  1992cited by this paper
• A deficiency of vitamin B6 is a plausible molecular basis of the retinopathy of patients with diabetes mellitus.

  1991cited by this paper
• Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals.

  1991cited by this paper
• Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

  1991cited by this paper
• Role of Pyridoxal Phosphate/Pyridoxine in Diabetes

  1990cited by this paper
• Inhibitory effects of pyridoxal phosphate, ascorbate and aminoguanidine on nonenzymatic glycosylation.

  1988cited by this paper
• SERUM PYRIDOXAL AND FOLATE CONCENTRATIONS IN DIABETICS

  1976cited by this paper
• Spectra and Ionization Constants of the Vitamin B6 Group and Related 3-Hydroxypyridine Derivatives1

  1955cited by this paper

• The Counterion (SO42− and NO3−) Effect on Crystallographic, Quantum-Chemical, Protein-, and DNA-Binding Properties of Two Novel Copper(II)–Pyridoxal-Aminoguanidine Complexes

  2024cites this paper
• Unexpected Products of Salicylidene-Aminoguanidine Reactions with Metal Ions—Synthesis and Structural Aspects

  2024cites this paper
• Solution equilibrium and redox properties of metal complexes with 2-formylpyridine guanylhydrazone derivatives: Effect of morpholine and piperazine substitutions.

  2024cites this paper
• Light-emitting diode-induced ellagic acid production in Drosera tokaiensis inhibits advanced glycation end-product formation

  2023cites this paper
• Solution Equilibrium Studies on Salicylidene Aminoguanidine Schiff Base Metal Complexes: Impact of the Hybridization with L-Proline on Stability, Redox Activity and Cytotoxicity

  2022cites this paper
• Inhibitory effect of phenolic compounds and plant extracts on the formation of advance glycation end products: A comprehensive review.

  2020cites this paper
• Advanced Glycation End Products in Chinese Medicine Mediated Aging Diseases: A Review.

  2020cites this paper
• Drosera tokaiensis extract containing multiple phenolic compounds inhibits the formation of advanced glycation end-products.

  2020cites this paper
• Pyridoxylidene aminoguanidine and its copper(II) complexes – Syntheses, structure and DFT calculations

  2017cites this paper
• Reactivity, Selectivity, and Reaction Mechanisms of Aminoguanidine, Hydralazine, Pyridoxamine, and Carnosine as Sequestering Agents of Reactive Carbonyl Species: A Comparative Study

  2016cites this paper
• Crystal structure of bis{4-bromo-2-[(carbamimidamidoimino)methyl]phenolato-κ3 N,N′,O}cobalt(III) nitrate dimethylformamide monosolvate

  2016cites this paper
• Syntheses and characterization of 2-acetylpyridine-aminoguanidine and its copper(II) complexes: Crystallographic and antimicrobial study

  2016cites this paper
• β-Resorcylidene aminoguanidine (RAG) dilates coronary arteries in an endothelium-independent manner

  2015cites this paper
• DW1029M, a novel botanical drug candidate, inhibits advanced glycation end-product formation, rat lens aldose reductase activity, and TGF-β1 signaling.

  2014cites this paper
• Protocatechualdehyde prevents methylglyoxal-induced mitochondrial dysfunction and AGEs-RAGE axis activation in human lens epithelial cells.

  2014cites this paper
• High throughput assay for evaluation of reactive carbonyl scavenging capacity☆

  2014cites this paper
• Inhibitory effect of paeoniflorin on methylglyoxal-mediated oxidative stress in osteoblastic MC3T3-E1 cells.

  2014cites this paper
• Synthesis, Characterization and X-ray Analysis of a Copper(II) Complex with Pyridoxal-aminoguanidine Ligand

  2014influential citation
• Synthesis, structure and photoluminescence properties of copper(II) and cobalt(III) complexes with pyridoxalaminoguanidine

  2013cites this paper
• The protection of 4,4'-diphenylmethane-bis(methyl) carbamate from Cortex Mori on advanced glycation end product-induced endothelial dysfunction: via inhibiting AGE formation or blocking AGEs-RAGE axis?

  2013cites this paper
• Non-Enzymatic Glycation of Aminotransferases and the Possibilities of Its Modulation

  2012cites this paper
• Impact of Glycation Inhibitors on the Biologic Activity of Recombinant Human Interferon-Gamma

  2012cites this paper
• Syntheses, crystal structures, and electrochemical characterizations of two octahedral iron(III) complexes with Schiff base of pyridoxal and aminoguanidine

  2012cites this paper
• Ellagic acid, a new antiglycating agent: its inhibition of Nϵ-(carboxymethyl)lysine.

  2012cites this paper
• J SYNTHESIS AND X-RAY CRYSTAL STRUCTURE OF A COPPER ( II ) COMPLEX WITH PYRIDOXAL-AMINOGUANIDINE ( PLAG ) LIGAND

  2011cites this paper
• SYNTHESIS AND X-RAY CRYSTAL STRUCTURE OF A COPPER(II) COMPLEX WITH PYRIDOXAL-AMINOGUANIDINE (PLAG) LIGAND

  2011cites this paper
• Inhibition of advanced glycation end-product formation on eye lens protein by rutin

  2011cites this paper
• Advanced glycation end products as biomarkers and gerontotoxins - A basis to explore methylglyoxal-lowering agents for Alzheimer's disease?

  2010cites this paper
• SYNTHESIS, CHARACTERIZATION AND NONLINEAR OPTICAL PROPERTIES OF FOUR NOVEL SCHIFF BASE COMPOUNDS

  2010cites this paper
• Glycation of aspartate aminotransferase by methylglyoxal, effect of hydroxycitric and uric acid

  2009cites this paper
• Design, Synthesis, and Evaluation of Carnosine Derivatives as Selective and Efficient Sequestering Agents of Cytotoxic Reactive Carbonyl Species

  2009cites this paper
• Characteristics, Formation, and Pathophysiology of Glucosepane: A Major Protein Cross-Link

  2009cites this paper
• Diabetic macular edema: pathogenesis and treatment.

  2009cites this paper
• Glycolaldehyde induces fibrinogen post-translational modification, delay in clotting and resistance to enzymatic digestion.

  2009cites this paper
• In vitro evaluation of the cytotoxicity and genotoxicity of resorcylidene aminoguanidine in human diploid cells B-HNF-1.

  2008cites this paper
• AGE and RAGE inhibitors in the treatment of diabetic retinopathy

  2007cites this paper
• Intervention strategies to inhibit protein carbonylation by lipoxidation‐derived reactive carbonyls

  2007cites this paper
• Carbonyl Stress Reduction in Peritoneal Dialysis Fluid: Development of a Novel High-Affinity Adsorption Bead

  2007cites this paper
• The road to advanced glycation end products: a mechanistic perspective.

  2007cites this paper
• Synthesis, spectroscopic and X-ray characterization of a copper(II) complex with the Schiff base derived from pyridoxal and aminoguanidine: NMR spectral studies of the ligand.

  2007cites this paper
• Effects of valsartan therapy on protein glycoxidation.

  2006cites this paper
• Lipoxidation‐Derived Reactive Carbonyl Species as Potential Drug Targets in Preventing Protein Carbonylation and Related Cellular Dysfunction

  2006cites this paper
• Effect of pyridoxylidene aminoguanidine on human diploid cells B-HEF-2: in vitro cytotoxicity test and cytogenetic analysis.

  2006cites this paper
• Mitochondrial function and toxicity: role of B vitamins on the one-carbon transfer pathways.

  2006cites this paper
• Novel therapeutics for diabetic micro- and macrovascular complications.

  2006cites this paper
• The effect of serotonin on epinephrine modulation of transepithelial ion transport in isolated frog skin.

  2006cites this paper
• From Molecular Footprints of Disease to New Therapeutic Interventions in Diabetic Nephropathy

  2005cites this paper
• The Maillard Reaction: Chemistry, Biochemistry and Implications

  2005cites this paper
• Impact of Glucose in Peritoneal Dialysis: Saint or Sinner?

  2005cites this paper
• Pyridoxal-aminoguanidine adduct is more effective than aminoguanidine in preventing neuropathy and cataract in diabetic rats.

  2004cites this paper
• Pyridoxal-Aminoguanidine Adduct is More Effective than Aminoguanidine in Preventing Neuropathy and Cataract in Diabetic Rats

  2004cites this paper
• Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts.

  2003cites this paper
• Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid.

  2003cites this paper
• Recent Concepts in the Molecular Biology of the Peritoneal Membrane – Implications for More Biocompatible Dialysis Solutions

  2003cites this paper
• Antioxidant activity of a Schiff base of pyridoxal and aminoguanidine.

  2003cites this paper
• Carbonyl Stress and Diabetic Complications

  2003cites this paper
• Advanced glycation end products in uremia.

  2003cites this paper
• A detective story for biomedical footprints towards new therapeutic interventions in diabetic nephropathy.

  2003cites this paper
• Aminoguanidine pyridoxal adduct is superior to aminoguanidine for preventing diabetic nephropathy in mice.

  2002cites this paper
• Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms.

  2002influential citation
• Two new nitric oxide synthase inhibitors: pyridoxal aminoguanidine and 8-quinolinecarboxylic hydrazide selectively inhibit basal but not agonist-stimulated release of nitric oxide in rat aorta.

  2002cites this paper
• Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes.

  2002cites this paper
• A glycation inhibitor, aminoguanidine and pyridoxal adduct, suppresses the development of diabetic nephropathy

  2002cites this paper
• Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid.

  2002cites this paper
• Effects of Nitric Oxide Synthase Inhibitors on Equine and Bovine Follicular Dynamics and Steroidogenesis.

  2001cites this paper
• Amadorins: novel post-Amadori inhibitors of advanced glycation reactions.

  1999cites this paper
• Inhibition of advanced protein glycation by a Schiff base between aminoguanidine and pyridoxal.

  1999cites this paper